← Back to Clinical Trials
Recruiting NCT00722527
Molecular Biology of Polycythemia and Thrombocytosis
Trial Parameters
Condition Polycythemia
Sponsor University of Utah
Study Type OBSERVATIONAL
Phase N/A
Enrollment 200
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2006-07
Completion 2028-07
All Conditions
Brief Summary
Our study is designed to characterize the clinical picture and genetic pattern of Polycythemia and Thrombocytosis. The purpose of this project is to find a gene and its mutation that causes these disorders. When this is accomplished, new therapies to control and eventually cure the disorder can be designed.
Eligibility Criteria
Inclusion Criteria: 1. Subjects with an elevated hemoglobin concentration (\>18 in males and \>16 in females) 2. Subjects with an elevated platelet count (\>450,000) Exclusion Criteria: 1. Subjects who have a known acquired cause of polycythemia and thrombocytosis 2. Subjects with heart disease, left to right heart shunt or severe pulmonary disease